These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32362618)

  • 41. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
    Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
    Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
    Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
    Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of CD7 and CD56 antigens in acute leukaemias.
    Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
    Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
    Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
    Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand.
    Auewarakul CU; Promsuwicha O; U-Pratya Y; Pattanapanyasat K; Issaragrisil S
    Asian Pac J Allergy Immunol; 2003 Sep; 21(3):153-60. PubMed ID: 15032399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87.
    Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD
    Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [CD34+ antigen expression relating to prognosis in acute myeloid leukemia].
    Li L; Wang R; Zhong D; Wen BZ; Abulaiti D; Lin ZQ; Jia M; Hao JP; Chen R; Guo XH; Wang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):812-4. PubMed ID: 16277848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T; Babusíková O
    Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of Heterogeneous Biological Characteristics and Prognosis-Related Factors in AL Patients with Mistranslation-Expressed Lymphoid and Myeloid-Related Antigen].
    Ma J; He GM; Liu H; Gao XY; Zhu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1263-1268. PubMed ID: 30295236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
    Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
    Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE; Ahlers J; Schäfer I; André M; Kerst G; Scheel-Walter HG; Schwarze CP; Pfeiffer M; Lang P; Handgretinger R; Ebinger M
    Pediatr Hematol Oncol; 2011 Mar; 28(2):91-9. PubMed ID: 21214408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
    Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
    Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunophenotypes in 115 patients with acute myeloid leukemia by multi-color flow cytometry].
    Wang XB; Yao JX; Zheng JE; Liu J; Li XQ; He YL; Yu JM; Yang J; Wei J; Liu ZP; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):250-3. PubMed ID: 15854286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interstitial 9q deletion is associated with CD7+ acute leukemia of myeloid and T lymphoid lineage.
    Ferrara F; Scognamiglio M; Di Noto R; Schiavone EM; Poggi V; Fiorillo A; Libertini R; Vicari L; Del Vecchio L; Sebastio L
    Leukemia; 1996 Dec; 10(12):1990-2. PubMed ID: 8946942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.